It is a chemicals private limited company based in Hyderabad, Telangana, India, established in 2016.
2016 | Hyderabad, Telangana, India | ActiveVentrocare Pharmaceuticals Private Limited, a active private limited company, was established on 19 October 2016 in Hyderabad, Telangana, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24230TG2016PTC112512. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Jagadeeswar Reddy Chowdavaram (Director), Vamsi Bhargavi Ponnapureddy (Director), Latha Kiran Chowdavaram (Director). Past directors included Rakshitha Pathuri. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at 3-3-81/1, Baghameeri, Near Hanuman Temple, Kukatpally,, Hyderabad, Telangana, 500072.
U24230TG2016PTC112512
112512
19 October 2016
₹0.10 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Ventrocare Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jagadeeswar Reddy Chowdavaram | Director | 19 Oct 2016 | Current |
| Vamsi Bhargavi Ponnapureddy | Director | 19 Oct 2016 | Current |
| Latha Kiran Chowdavaram | Director | 16 Apr 2018 | Current |
| Venkat Subba Reddy Choudavaram | Director | 19 Oct 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Aug 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ventrocare Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 78.14% decrease. The company also saw a substantial improvement in profitability, with a 51.26% increase in profit. The company's net worth observed a substantial decline by a decrease of 17.1%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Ventrocare Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Ventrocare Pharmaceuticals has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Ventrocare Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ventrocare Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Ventrocare Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was recorded as a recent event.
Ventrocare Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad. was recorded as a recent event.
Progress on Latha Kiran Chowdavaram was appointed as a Director was appointed as a Director on 16 Apr 2018 & has been associated with this company since 7 years 8 months . was documented.
The activity Jagadeeswar Reddy Chowdavaram was appointed as a Director was appointed as a Director on 19 Oct 2016 & has been associated with this company since 9 years 1 month . was completed.
Vamsi Bhargavi Ponnapureddy was appointed as a Director was appointed as a Director on 19 Oct 2016 & has been associated with this company since 9 years 1 month . was recorded as a recent event.
Venkat Subba Reddy Choudavaram was appointed as a Director was appointed as a Director on 19 Oct 2016 & has been associated with this company since 9 years 1 month . was recorded as a recent event.
The CIN of Ventrocare Pharmaceuticals Private Limited is U24230TG2016PTC112512.
Ventrocare Pharmaceuticals Private Limited is headquartered at 3-3-81/1, Baghameeri, Near Hanuman Temple, Kukatpally,, Hyderabad, Telangana, 500072.
Ventrocare Pharmaceuticals Private Limited was incorporated on 19 October 2016.
The current directors of Ventrocare Pharmaceuticals Private Limited are
The primary industry of Ventrocare Pharmaceuticals Private Limited is Chemicals.
Ventrocare Pharmaceuticals Private Limited is unlisted.
The authorized capital of Ventrocare Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Ventrocare Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX